Literature DB >> 894742

Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication.

A Tagliabue, A Mantovani, N Polentarutti, A Vecchi, F Spreafico.   

Abstract

The effect of four immunomodulators (BCG, Corynebacterium parvum, pyran copolymer, and levamisole) on the cellular arm of antibody-dependent cellular cytotoxicity (ADCC) was investigated in mice with 51Cr-labeled chicken erythrocytes employed as targets. All these drugs, except levamisole, stimulated the effector cells of ADCC in the spleen, but the kinetics of their effect differed. Stimulation of the effector cells of ADCC peaked on day 15 after injection of BCG and C. parvum and on day 7 after injection of pyran, which was less efficient in this respect than the two bacterial immunostimulants. The increase in ADCC activity caused by BCG and C. parvum was eliminated by treatment with carbonyl iron of the splenocyte suspensions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894742     DOI: 10.1093/jnci/59.3.1019

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.

Authors:  N Kiger; M Bruley-Rosset; R Huchet; G Mathe
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

2.  Decreased monocyte antibody-dependent cell-mediated toxicity in stage I-II malignant melanoma. Augmentation by subcutaneous Corynebacterium parvum.

Authors:  J L Murray; E T Lee
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Natural cytotoxic activity in human lungs.

Authors:  C Bordignon; F Villa; A Vecchi; R Giavazzi; M Introna; R Avallone; A Mantovani
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

4.  Effects of mitogens on ADCC activity and Fc receptor bearing cells.

Authors:  A Hügin; A Matter
Journal:  Experientia       Date:  1983-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.